Enabling smarter brand decisions through integrated insight and execution.
We help brand and commercial leaders make smarter, faster decisions across the product lifecycle and commercialization journey. From early strategy and market insight to launch and in-market optimization, our integrated expertise in research, analytics, and execution enables teams to shape positioning, strengthen customer engagement, and drive sustained brand growth.
Meet the experts behind the solutions delivering meaningful impact for our clients.
Karan sits on Putnam’s Commercial Practice Leadership team, advising US and European biopharma on pipeline and in-line products. His focus includes go-to-market strategy, opportunity assessment, forecasting, and portfolio optimization.
As President of Putnam, Matt leads a team focused on strategic acuity and patient impact. He has partnered with global biopharma across therapeutic areas from pipeline shaping to launch, applying structured thinking and objective analysis to drive results.
Tim has spent 10 years with STEM, shaping the organization across Europe and globally through roles including Project Director, Country Manager, Head of International Operations, Europe Regional Leader, and President of Europe and Emerging Markets.
.
.
Sarah is an experienced healthcare market research leader specialising in large-scale syndicated tracking programmes, in particular chart audit studies. She brings a strong record of delivering rigorous, actionable insights across global markets and therapy areas.
Mike is a leader in Inizio’s Customer Experience practice, helping clients improve customer engagement and operational performance through strategy, technology, and experience design. His focus includes omnichannel transformation, brand marketing, MarTech, and patient experience.
Access the most up-to-date health and life sciences insights and resources.
In pharma commercialization, AI and analogs set the stage, but human insight drives strategies that break precedent and win markets
In pharma commercialization, AI and analogs set the stage, but human insight drives strategies that break precedent and win markets
Integrated research uncovered nuanced patient journeys and treatment shifts to guide clinical strategy and avoid portfolio cannibalization
A top 10 life sciences firm drove $300M impact via enterprise-wide transformation, PMO scaling & strategy to tackle the patent cliff.
Let’s discuss how we can help you.